View in EDS HTML Full Text PDF Full Text

Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.

Saved in:
Bibliographic Details
Title: Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.
Authors: Smith SM; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA., Zhang S; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA., Sundaram V; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA., Roth M; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Andolina JR; Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, New York, USA., Schapira L; Department of Medicine, Division of Oncology, Stanford Cancer Institute and Stanford University School of Medicine, Palo Alto, California, USA., Sakamoto KM; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA., Kolb EA; Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Nemours Center for Cancer and Blood Disorders, Wilmington, Delaware, USA., Hijiya N; Pediatric Hematology, Oncology, and Stem Cell Transplant, Columbia University Irving Medical Center, New York, New York, USA., Chaudhury S; Department of Pediatrics, Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Source: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2022 Aug; Vol. 39 (5), pp. 453-467. Date of Electronic Publication: 2021 Dec 17.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0669 (Electronic) Linking ISSN: 08880018 NLM ISO Abbreviation: Pediatr Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34918996
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Smith+SM%22">Smith SM</searchLink>; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Sundaram+V%22">Sundaram V</searchLink>; Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Roth+M%22">Roth M</searchLink>; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Andolina+JR%22">Andolina JR</searchLink>; Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Schapira+L%22">Schapira L</searchLink>; Department of Medicine, Division of Oncology, Stanford Cancer Institute and Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Sakamoto+KM%22">Sakamoto KM</searchLink>; Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Kolb+EA%22">Kolb EA</searchLink>; Department of Pediatrics, Nemours/Alfred I. duPont Hospital for Children, Nemours Center for Cancer and Blood Disorders, Wilmington, Delaware, USA.<br /><searchLink fieldCode="AU" term="%22Hijiya+N%22">Hijiya N</searchLink>; Pediatric Hematology, Oncology, and Stem Cell Transplant, Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Chaudhury+S%22">Chaudhury S</searchLink>; Department of Pediatrics, Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228700164%22">Pediatric hematology and oncology</searchLink> [Pediatr Hematol Oncol] 2022 Aug; Vol. 39 (5), pp. 453-467. <i>Date of Electronic Publication: </i>2021 Dec 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8700164 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-0669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208880018%22">08880018 </searchLink><i>NLM ISO Abbreviation: </i>Pediatr Hematol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34918996
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/08880018.2021.2017085
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 453
    Titles:
      – TitleFull: Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Smith SM
      – PersonEntity:
          Name:
            NameFull: Zhang S
      – PersonEntity:
          Name:
            NameFull: Sundaram V
      – PersonEntity:
          Name:
            NameFull: Roth M
      – PersonEntity:
          Name:
            NameFull: Andolina JR
      – PersonEntity:
          Name:
            NameFull: Schapira L
      – PersonEntity:
          Name:
            NameFull: Sakamoto KM
      – PersonEntity:
          Name:
            NameFull: Kolb EA
      – PersonEntity:
          Name:
            NameFull: Hijiya N
      – PersonEntity:
          Name:
            NameFull: Chaudhury S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1521-0669
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Pediatric hematology and oncology
              Type: main
ResultId 1